Literature DB >> 6976932

Population studies of the HLA-linked SB antigens.

S Shaw, R J Duquesnoy, P L Smith.   

Abstract

Using allogeneic T-cell recognition we have previously defined five new histocompatibility antigens designated "SB" antigens. To standardize typing for these antigens, cryopreserved, primed lymphocytes are now used as standard reagents and a technique of cluster analysis has been modified to score typing results objectively. Two primed lymphocyte reagents are used to define each SB antigen; although derived from independent responder-stimulator combinations, the concordance between the reagents is good (r is greater than 0.86). The SB-antigen distribution in a population of 215 normal donors in consistent with Hardy-Weinberg equilibrium of alleles of a single locus. Estimated gene frequencies ranged between 3 percent (SB5) and 36 percent (SB4) with 31 percent blanks. Analysis of association between the SB antigens and A, B, DR antigens in 200 normal donors revealed that associations were generally weak with a few exceptions, in particular, the A1, B8, DR3, SB1 "haplotype" and also the B7, DR2, SB5 "haplotype".

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6976932     DOI: 10.1007/BF00344308

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  11 in total

1.  Human T lymphocytes clones reactive in primed lymphocyte typing and cytotoxicity.

Authors:  F H Bach; H Inouye; J A Hank; B J Alter
Journal:  Nature       Date:  1979-09-27       Impact factor: 49.962

2.  Mixed lymphocyte reactivity of human lymphocytes primed in vitro. I. Secondary response to allogenic lymphocytes.

Authors:  D Fradelizi; J Dausset
Journal:  Eur J Immunol       Date:  1975-05       Impact factor: 5.532

3.  Immunogenetic analysis of an unusual HLA region recombination by intrafamilial MLR, PLT, and CMC.

Authors:  S Shaw; G J O'Neill; G M Shearer
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

4.  Three closely linked genetic systems relevant to transplantation.

Authors:  E J Yunis; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

5.  Population genetics of the MLC response: typing for MLC determinants using homozygous and heterozygous reference cells.

Authors:  W Mempel; H Grosse-Wilde; P Baumann; B Netzel; I Steinbauer-Rosenthal; S Scholz; J Bertrams; E D Albert
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

6.  Hu-1: Major histocompatibility locus in man.

Authors:  F H Bach; D B Amos
Journal:  Science       Date:  1967-06-16       Impact factor: 47.728

7.  HLA-linked B cell alloantigens of a new segregant series: population and family studies of the SB antigens.

Authors:  S Shaw; M S Pollack; S M Payne; A H Johnson
Journal:  Hum Immunol       Date:  1980-09       Impact factor: 2.850

8.  Human cytotoxic response in vitro to trinitrophenyl-modified autologous cells. I. T cell recognition of TNP in association with widely shared antigens.

Authors:  S Shaw; D L Nelson; G M Shearer
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

9.  HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.

Authors:  M J Sheehy; P M Sondel; M L Bach; R Wank; F H Bach
Journal:  Science       Date:  1975-06-27       Impact factor: 47.728

10.  Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.

Authors:  S Shaw; A H Johnson; G M Shearer
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  16 in total

1.  HLA-DP/DR interaction in children with juvenile rheumatoid arthritis.

Authors:  C Van Kerckhove; L Luyrink; M S Elma; W P Maksymowych; J E Levinson; M G Larson; E Choi; D N Glass
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  HLA-DP types of homozygous typing cells: DPw3 found in three Dw19 HTC.

Authors:  R Wank; H Grosse-Wilde
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  Biochemical polymorphism of the HLA-DP heavy chain.

Authors:  V Lotteau; L Teyton; M M Tongio; A Soulier; M Thomsen; M Sasportes; D Charron
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cells.

Authors:  G Pawelec; S Shaw; M Schneider; A Rehbein; P Wernet
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Mapping SB in relation to HLA and GLO1 using cells from first-cousin marriage offspring.

Authors:  A Termijtelen; P Meera Khan; S Shaw; J J van Rood
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  SB types of HLA-D homozygous typing cells.

Authors:  P Wernet; S Shaw; C Brautbar; E Westphal; G Pawelec
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex.

Authors:  M Roux-Dosseto; C Auffray; J W Lillie; J M Boss; D Cohen; R DeMars; C Mawas; J G Seidman; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones.

Authors:  J Arroyo; R Díez-Orejas; A M Alvarez; S Shaw; M Sánchez-Pérez
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.

Authors:  Y Matsui; S M Alosco; Z Awdeh; R J Duquesnoy; P L Page; R J Hartzman; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.